MXPA02010502A - Un dispositivo intravaginal que contiene progesterona, util como inductor del celo en bovinos productores de carne y leche y el procedimiento para prepararlo. - Google Patents
Un dispositivo intravaginal que contiene progesterona, util como inductor del celo en bovinos productores de carne y leche y el procedimiento para prepararlo.Info
- Publication number
- MXPA02010502A MXPA02010502A MXPA02010502A MXPA02010502A MXPA02010502A MX PA02010502 A MXPA02010502 A MX PA02010502A MX PA02010502 A MXPA02010502 A MX PA02010502A MX PA02010502 A MXPA02010502 A MX PA02010502A MX PA02010502 A MXPA02010502 A MX PA02010502A
- Authority
- MX
- Mexico
- Prior art keywords
- proceses
- estrus synchronization
- devices containing
- intravaginal devices
- containing progesterone
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61D—VETERINARY INSTRUMENTS, IMPLEMENTS, TOOLS, OR METHODS
- A61D7/00—Devices or methods for introducing solid, liquid, or gaseous remedies or other materials into or onto the bodies of animals
Landscapes
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Materials For Medical Uses (AREA)
- Two-Way Televisions, Distribution Of Moving Picture Or The Like (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Un dispositivo intravaginal que posee progesterona, util como inductor del celo en bovinos, que comprende una estructura de anclaje que consta de una matriz de fenil-vinil- silicona, reticulada con peroxido, homogeneamente embebida con progesterona natural. En una forma de realizacion, la cantidad de progesterona embebida en la matriz es de 1, 5 g o menos. Tipicamente, la estructura de anclaje es un cuerpo cruciforme, con ramas tubulares que definen un conducto interior continuo comunicado con el exterior mediante orificios transversalmente dispuestos, alojandose dentro de dicho conducto interior un inserto de nylon cuya seccion transversal conjuntamente con la seccion transversal del conducto interior define un espacio libre. Como accesorios para el tercer uso consecutivo del dispositivo, el dispositivo puede estar provisto de vainas o camisas impregnadas con progesterona, realizadas con el mismo material que el dispositivo. Tambien se describe un procedimiento para preparar el dispositivo.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ARP010104978A AR026386A1 (es) | 2001-10-24 | 2001-10-24 | Un dispositivo intravaginal que contiene progesterona, util como inductor de celo en bovinos productores de carne y leche, y el procedimiento paraprepararlo |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA02010502A true MXPA02010502A (es) | 2004-06-09 |
Family
ID=37515149
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA02010502A MXPA02010502A (es) | 2001-10-24 | 2002-10-24 | Un dispositivo intravaginal que contiene progesterona, util como inductor del celo en bovinos productores de carne y leche y el procedimiento para prepararlo. |
Country Status (4)
Country | Link |
---|---|
US (2) | US6805877B2 (es) |
AR (1) | AR026386A1 (es) |
MX (1) | MXPA02010502A (es) |
UY (1) | UY27507A1 (es) |
Families Citing this family (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6569152B2 (en) * | 2000-03-21 | 2003-05-27 | Farrington Pharmaceuticals, Llc | Sustained release delivery systems for solutes |
JP2005533782A (ja) * | 2002-06-17 | 2005-11-10 | アルザ コーポレイション | 流体ビヒクル中に分散した浸透剤を含む、押出し力が早く零次になる機関を有する浸透送出システム |
AR043476A1 (es) * | 2004-09-09 | 2005-08-03 | Dvoskin Victor Oscar | Dispositivo de administracion regulada de sustancias para la insercion en una cavidad corporal y procedimiento para fabricar un medio de soporte de dichas sustancias |
US7595218B2 (en) * | 2006-01-09 | 2009-09-29 | Macronix International Co., Ltd. | Programmable resistive RAM and manufacturing method |
EP2219554A4 (en) * | 2007-11-29 | 2011-05-25 | Gregg A Jackson | PROGESTER-CONTAINING COMPOSITIONS AND DEVICES |
WO2011037444A2 (es) * | 2009-09-28 | 2011-03-31 | Carlos Alberto Barcelo Rojas | Método de palpación de los estadios fisioreproductivos del útero |
US8882748B2 (en) * | 2009-10-08 | 2014-11-11 | Palo Alto Research Center Incorporated | Transmucosal drug delivery device and method including chemical permeation enhancers |
US9014799B2 (en) * | 2009-10-08 | 2015-04-21 | Palo Alto Research Center Incorporated | Transmucosal drug delivery device and method including electrically-actuated permeation enhancement |
US9017310B2 (en) * | 2009-10-08 | 2015-04-28 | Palo Alto Research Center Incorporated | Transmucosal drug delivery device and method including microneedles |
CN202152703U (zh) * | 2011-02-11 | 2012-02-29 | 通用电气公司 | 用于操作压缩气体燃料的*** |
PT2782584T (pt) | 2011-11-23 | 2021-09-02 | Therapeuticsmd Inc | Preparações e terapias de substituição para hormonoterapias naturais combinadas |
US9301920B2 (en) | 2012-06-18 | 2016-04-05 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
US20150196640A1 (en) | 2012-06-18 | 2015-07-16 | Therapeuticsmd, Inc. | Progesterone formulations having a desirable pk profile |
US10806740B2 (en) | 2012-06-18 | 2020-10-20 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
US20130338122A1 (en) | 2012-06-18 | 2013-12-19 | Therapeuticsmd, Inc. | Transdermal hormone replacement therapies |
US10806697B2 (en) | 2012-12-21 | 2020-10-20 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US20140088345A1 (en) * | 2012-09-27 | 2014-03-27 | Palo Alto Research Center Incorporated | Single channel, multiple drug delivery device and methods |
US9999720B2 (en) | 2012-09-27 | 2018-06-19 | Palo Alto Research Center Incorporated | Drug reconstitution and delivery device and methods |
US9005108B2 (en) | 2012-09-27 | 2015-04-14 | Palo Alto Research Center Incorporated | Multiple reservoir drug delivery device and methods |
US11266661B2 (en) | 2012-12-21 | 2022-03-08 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10537581B2 (en) | 2012-12-21 | 2020-01-21 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US9180091B2 (en) | 2012-12-21 | 2015-11-10 | Therapeuticsmd, Inc. | Soluble estradiol capsule for vaginal insertion |
US10471072B2 (en) | 2012-12-21 | 2019-11-12 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US11246875B2 (en) | 2012-12-21 | 2022-02-15 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10568891B2 (en) | 2012-12-21 | 2020-02-25 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US9744341B2 (en) | 2013-01-15 | 2017-08-29 | Palo Alto Research Center Incorporated | Devices and methods for intraluminal retention and drug delivery |
US9297083B2 (en) | 2013-12-16 | 2016-03-29 | Palo Alto Research Center Incorporated | Electrolytic gas generating devices, actuators, and methods |
CA2947767A1 (en) | 2014-05-22 | 2015-11-26 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
US9801660B2 (en) | 2014-07-31 | 2017-10-31 | Palo Alto Research Center Incorporated | Implantable fluid delivery devices, systems, and methods |
US10278675B2 (en) | 2014-07-31 | 2019-05-07 | Palo Alto Research Center Incorporated | Implantable estrus detection devices, systems, and methods |
US10328087B2 (en) | 2015-07-23 | 2019-06-25 | Therapeuticsmd, Inc. | Formulations for solubilizing hormones |
CA3020153A1 (en) | 2016-04-01 | 2017-10-05 | Therapeuticsmd, Inc. | Steroid hormone pharmaceutical composition |
WO2017173044A1 (en) | 2016-04-01 | 2017-10-05 | Therapeuticsmd Inc. | Steroid hormone compositions in medium chain oils |
US11633405B2 (en) | 2020-02-07 | 2023-04-25 | Therapeuticsmd, Inc. | Steroid hormone pharmaceutical formulations |
US20230049584A1 (en) * | 2020-02-07 | 2023-02-16 | Agilis International Limited | Device for insertion into a cavity |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3710795A (en) * | 1970-09-29 | 1973-01-16 | Alza Corp | Drug-delivery device with stretched, rate-controlling membrane |
US3995631A (en) * | 1971-01-13 | 1976-12-07 | Alza Corporation | Osmotic dispenser with means for dispensing active agent responsive to osmotic gradient |
US3938515A (en) * | 1971-12-20 | 1976-02-17 | Alza Corporation | Novel drug permeable wall |
US4188951A (en) * | 1972-08-17 | 1980-02-19 | Alza Corporation | Intrauterine system embracing selected copolymeric membranes for administering beneficial agent |
IL48277A (en) * | 1974-10-18 | 1978-03-10 | Schering Ag | Vaginal ring |
US4144317A (en) * | 1975-05-30 | 1979-03-13 | Alza Corporation | Device consisting of copolymer having acetoxy groups for delivering drugs |
US4292965A (en) * | 1978-12-29 | 1981-10-06 | The Population Council, Inc. | Intravaginal ring |
US4249531A (en) * | 1979-07-05 | 1981-02-10 | Alza Corporation | Bioerodible system for delivering drug manufactured from poly(carboxylic acid) |
US4326511A (en) * | 1979-10-05 | 1982-04-27 | Zimerman Clota E | Intrauterine contraceptive device |
GB2079158B (en) * | 1980-06-09 | 1985-01-09 | Ahi Operations Ltd | Intra-vaginal devices |
US4629449A (en) * | 1982-07-29 | 1986-12-16 | Alza Corporation | Vaginal dispenser for dispensing beneficial hormone |
US4961931A (en) * | 1982-07-29 | 1990-10-09 | Alza Corporation | Method for the management of hyperplasia |
US4649042A (en) * | 1984-05-31 | 1987-03-10 | Eli Lilly And Company | Rumen delivery device |
FR2618329B1 (fr) * | 1987-07-22 | 1997-03-28 | Dow Corning Sa | Procede de fabrication d'un anneau capable d'assurer la liberation d'un agent therapeutique, et anneau fabrique par ce procede |
NZ286492A (en) | 1996-05-01 | 1998-02-26 | Dec International Nz Ltd Subst | Intra vaginal devices for synchronising oestrus of animals is made up of cured silicone rubber material with 5% by weight of progesterone |
AU723217B2 (en) * | 1997-05-28 | 2000-08-24 | Interag | Intra-vaginal device for pigs |
-
2001
- 2001-10-24 AR ARP010104978A patent/AR026386A1/es active IP Right Grant
-
2002
- 2002-06-21 US US10/176,801 patent/US6805877B2/en not_active Expired - Fee Related
- 2002-10-21 UY UY27507A patent/UY27507A1/es active IP Right Grant
- 2002-10-24 MX MXPA02010502A patent/MXPA02010502A/es active IP Right Grant
-
2004
- 2004-08-19 US US10/922,493 patent/US6939558B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US6805877B2 (en) | 2004-10-19 |
US6939558B2 (en) | 2005-09-06 |
AR026386A1 (es) | 2003-02-12 |
UY27507A1 (es) | 2003-04-30 |
US20050021009A1 (en) | 2005-01-27 |
US20030130558A1 (en) | 2003-07-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MXPA02010502A (es) | Un dispositivo intravaginal que contiene progesterona, util como inductor del celo en bovinos productores de carne y leche y el procedimiento para prepararlo. | |
IL153497A0 (en) | Rapidly expanding composition for gastric retention and controlled release of therapeutic agents, and dosage forms including the composition | |
EP1186293A3 (en) | Intermittent administration of a growth hormone secretagogue | |
MY128628A (en) | Bioadhesive progressive hydration tablets | |
AU2001253479A1 (en) | Targeted therapeutic agent release devices and methods of making and using the same | |
HUP0301400A3 (en) | Composition and dosage form for delayed gastric release of alendronate and/or other bis-phosphpnates | |
GB2376049B (en) | Controlling activation of devices | |
HK1060305A1 (en) | Contraception process and administration form for the same | |
WO2003028225A3 (en) | Wireless synchronous time system | |
MY133365A (en) | Extended release buccal bioadhesive tablet | |
AU147234S (en) | A set of bandage frames | |
IL154805A0 (en) | System for the application of pesticides | |
TW530638U (en) | Device for insertion of Tampon | |
IS2691B (is) | Áætlun um lyfjaskammta og lyfjasamsetningar til getnaðarvarnar í neyð | |
UA90077C2 (uk) | Антидисритмічні агенти для лікування тазового болю, що призначаються вагінально | |
HK1075005A1 (en) | Matrix film tablets for the controlled release of natural mixtures of conjugated estrogen | |
EP1304134A4 (en) | AUXILIARY DEVICE FOR APPLYING AN ADHESIVE | |
AU2001227030A1 (en) | Pharmaceutical composition for controlled release of an active ingredient | |
SG88832A1 (en) | Clasp for watch wristband | |
MXPA01002595A (es) | Mordaza para componentes de intrerconexion de aparatos de apuntalamiento. | |
EE200200103A (et) | Mesoprogestiinid (progesterooniretseptori modulaatorid) naise kontratseptiivide komponendina | |
IL155360A0 (en) | Processes for the isolation or purification of plavastatin and compositions containing plavastatin | |
AU2001275244A1 (en) | Starter kit for low dose oral contraceptives | |
AU2001259627A1 (en) | Cell line for the expression of an alpha2delta2 calcium channel subunit | |
EP1322315A4 (en) | FORMULATIONS CONTAINING URSODESOXYCHOLIC ACID FOR REDUCING OR SUPPRESSING TOXICITY OF ENDOCRINE MODULATORS |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |